Core Laboratories Inc. /DE/ Quarterly Operating Income (Loss) in USD from Q2 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Core Laboratories Inc. /DE/ quarterly/annual Operating Income (Loss) history and growth rate from Q2 2022 to Q3 2024.
  • Core Laboratories Inc. /DE/ Operating Income (Loss) for the quarter ending September 30, 2024 was $19.8M, a 35% increase year-over-year.
  • Core Laboratories Inc. /DE/ Operating Income (Loss) for the twelve months ending September 30, 2024 was $59M.
  • Core Laboratories Inc. /DE/ annual Operating Income (Loss) for 2023 was $54.6M, a 31.6% increase from 2022.
  • Core Laboratories Inc. /DE/ annual Operating Income (Loss) for 2022 was $41.5M, a 8.26% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $59M $19.8M +$5.13M +35% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-24
Q2 2024 $53.8M $16M -$2.9M -15.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $56.7M $8.57M +$2.09M +32.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $54.6M $14.6M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 $14.7M +$27K +0.18% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-24
Q2 2023 $18.9M +$7.25M +62.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 $6.48M Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q3 2022 $14.6M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $11.7M Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.